Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia | Zendy

Gil D. Rabinovici | Zendy; Constantine Gatsonis | Zendy; Charles Apgar | Zendy; Kiran Chaudhary | Zendy; Ilana F. Gareen | Zendy; Lucy Hanna | Zendy; James A. Hendrix | Zendy; Bruce E. Hillner | Zendy; Cynthia Olson | Zendy; Orit H. LesmanSegev | Zendy; Justin Romanoff | Zendy; Barry A. Siegel | Zendy; Rachel A. Whitmer | Zendy; María C. Carrillo | Zendy

Open Access

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Author(s) -

Gil D. Rabinovici,

Constantine Gatsonis,

Charles Apgar,

Kiran Chaudhary,

Ilana F. Gareen,

Lucy Hanna,

James A. Hendrix,

Bruce E. Hillner,

Cynthia Olson,

Orit H. LesmanSegev,

Justin Romanoff,

Barry A. Siegel,

Rachel A. Whitmer,

María C. Carrillo

Publication year - 2019

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2019.2000

Subject(s) - dementia , medicine , positron emission tomography , disease , etiology , pittsburgh compound b , cognitive decline , alzheimer's disease , radiology

Amyloid positron emission tomography (PET) detects amyloid plaques in the brain, a core neuropathological feature of Alzheimer disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research